Abiopharma

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Kymera Therapeutics Announces Proposed Public Offering

Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock

Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants

Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting

Lilly declares first-quarter 2026 dividend

Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process